InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-25.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Emany Sravan Kumar, Chief Financial Officer. Director active across 4 companies, notably Ironwood Pharmaceuticals INC. In total, 20 reports have been recorded. Breakdown: 2 buys · 3 sells. Total volume traded: €636k. History available since 6 December 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Emany Sravan Kumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
23,855 sharesCommon StockSEC:0001104659-26-074749:0
31,750 shares0Common StockSEC:0001193125-26-140513:0
11,006 shares0Common StockSEC:0001193125-26-076897:0
6,294 shares@ US$27.10100.0% of flowCommon StockSEC:0001193125-26-002448:0
53,750 shares0Common StockSEC:0001104659-25-046868:0
80,000 shares0Common StockSEC:0000950170-25-000624:0
11,001 shares@ US$4.083.5% of flowClass A Common StockSEC:0000950170-24-129227:0
53,750 shares0Common StockSEC:0001104659-24-065701:0
18,280 shares@ US$6.649.1% of flowClass A Common StockSEC:0000950170-24-062372:0
37,120 shares0Class A Common StockSEC:0000950170-24-029907:0
10,684 shares@ US$9.387.5% of flowClass A Common StockSEC:0000950170-24-027128:0
Canonical exit: 2 Jun 2024 (T+90)
65,312 shares0Class A Common StockSEC:0000950170-24-015545:0
41,332 shares@ US$14.9046.4% of flowClass A Common StockSEC:0000950170-24-013817:0
85,000 shares0Class A Common StockSEC:0001209191-24-001903:0
6,661 shares@ US$9.444.7% of flowClass A Common StockSEC:0001209191-23-056023:0
177,570 shares0Common StockSEC:0001104659-23-119212:0
36,072 shares@ US$8.3268.2% of flowClass A Common StockSEC:0001209191-23-049781:0
Canonical exit: 14 Dec 2023 (T+90)
74,236 shares0Class A Common StockSEC:0001209191-23-017878:0
6,578 shares@ US$11.566.0% of flowClass A Common StockSEC:0001209191-22-058611:0
85,000 shares0Class A Common StockSEC:0001209191-21-068513:0
20 of 20 declarations
About Emany Sravan Kumar
Emany Sravan Kumar is Chief Financial Officer. He has 20 filings in total, and across the 20 sampled recent filings, the reported amounts are EUR 374569 of buys and EUR 261413 of sells, with activity ranging from 2021-12-08 to 2026-06-16. The largest filings concern Ironwood Pharmaceuticals INC and Beam Therapeutics Inc., and the modal transaction nature is Attribution.
